German molecular Dx company obtains $16.3M in financing

04/23/2013 | GenomeWeb Daily News (free registration)

Curetis has raised $16.3 million in Series B financing, which it will use to support its operational and commercial expansion. The Germany-based firm plans to submit an FDA 510(k) clearance application next year for its Unyvero system, a DNA-based diagnostics platform that can detect multiple antibiotic-resistant organisms and bacteria from a single sample in one go.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA